The Most Current Information Available from Leading Scientists and Clinical Trials World-wide
Application of Technology to Make Any Size of Study Self-Managing and Affordable
The Latest Updates on Diseases Treatable Through Regenerative Medicine
Opinions from Regenetek and Leading Authorities in Regenerative Medicine
Doug Broeska is a PhD Medical Researcher and CEO of Regenetek Inc, a Canadian Biotech Research firm working with several hospitals and clinics world-wide to develop medical procedural protocols for neurodegenerative disease management.